Stock Taper
SCREENER COMPARE ANY 2 STOCKS
LQDA
LIQUIDIA CORPORATION
NASDAQ
$68.63
▼ DOWN 1.51% (-1.05)

KEY STATISTICS

Market Cap$6.11 B
52w High$93.61
52w Low$21.15
Dividend Yield—
Frequency—
P/E490.21
Volume931.65K
Shares Out.88.93M

COMPANY

LEADERSHIP

Roger A. Jeffs
CHIEF EXECUTIVE
Roger A. Jeffs

COMPENSATION 2026

Salary$824,000
Stock Awards$5,590,992
Incentive Plan Pay$1,254,400
All Other Comp.$18,344
Total$7,712,736

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 26, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
216

PRICE TARGET

Target High$130.00
Target Low$36.00
Target Median$108.00
Target Consensus$98.11

UPCOMING EARNINGS

DateNov 2, 2026
DayMonday
Rev. Est.$205.91M
NOV
2
MON

PRICE

$68.63 ▼ DOWN 1.51% (−$1.05)
$68.25$69.00$69.75$70.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM68.63

About Liquidia Corporation

https://www.liquidia.com ↗

Liquidia Corporation, founded in 2004 and based in Morrisville, NC, develops and commercializes biopharmaceutical products like YUTREPIA for pulmonary arterial hypertension and distributes generic treprostinil injection in the U.S.

INDUSTRY

Medical - Pharmaceuticals

A PRODUCT LIQUIDIA CORPORATION IS KNOWN FOR

YUTREPIA™ (treprostinil) inhalation powder
YUTREPIA™ (treprostinil) inhalation powder

YUTREPIA, FDA-approved inhaled treprostinil developed with Liquidia’s PRINT® technology, treats PAH and PH-ILD via a compact device, serving as Liquidia’s flagship product in the rare cardiopulmonary market.

COMPETITORS

COMPETITOR
GOSS COMPARE
MNKD COMPARE
UTHR COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$51.67M $90.1M ▲$129.88M ▲$170.38M ▲
Service$2.67M $5.04M ▲$2.98M ▼$1.3M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
175
LISTED HERE
26
RANKED BY POSITION SIZE
XSMH.TO
0.27% · 4.3M
VTS.AX
0.01% · 2.3M
SPSM
0.27% · 650.3K
SCHA
0.10% · 333.7K
PJP
2.76% · 221.6K
PSC
0.44% · 176.0K
JSMD
1.01% · 159.4K
FESM
0.14% · 134.8K
FYC
0.57% · 119.6K
QMOM
1.52% · 95.7K
XRS2.DE
0.15% · 63.8K
DFAS
0.03% · 62.0K
USVM
0.21% · 54.0K
FSCC
0.95% · 51.5K
BR
BRES
0.40% · 39.8K
RSSL
0.16% · 33.8K
GSSC
0.17% · 27.6K
BBP
1.20% · 20.6K
BBSC
0.18% · 19.3K
SZNE
2.20% · 14.9K
RTWP.L
0.28% · 8.9K
ZSML.TO
0.26% · 6.7K
TYNE
3.95% · 6.4K
EH
EHLS
0.47% · 4.0K
JHSC
0.03% · 3.1K
RFLR
0.21% · 3.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
61.93%
HOLDERS
412
TOP 12 OF 412 · RANKED BY POSITION SIZE
Blackrock, Inc.
10.8M sh · $860.17M
Farallon Capital Management LLC
8.7M sh · $326.68M
Caligan Partners LP
8.1M sh · $184.62M
Blackrock Inc.
4.2M sh · $50.89M
Vanguard Group Inc
4.0M sh · $138.44M
Findell Capital Management LLC
3.5M sh · $279.22M
State Street Corp
3.0M sh · $241.61M
Canaan Partners Viii LLC
2.9M sh · $12.48M
Goldman Sachs Group Inc
2.8M sh · $63.27M
Opaleye Management Inc.
2.6M sh · $59.47M
Bank Of America Corp /De/
2.3M sh · $86.34M
Geode Capital Management, LLC
2.1M sh · $169.16M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets5
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score3

INSIDER TRADES

★
OFFICER: CHIEF BUSINESS OFFICER
Adair Jason
Sale · 31.8K shares
2026-08-21
★
OFFICER: CHIEF BUSINESS OFFICER
Adair Jason
Sale · 41.8K shares
2026-08-21
★
OFFICER: CHIEF BUSINESS OFFICER
Adair Jason
Purchase · 238 shares
2026-08-21
★
OFFICER: CHIEF BUSINESS OFFICER
Adair Jason
Sale · 10.8K shares
2026-08-21

SECTORS PEERS

PEERPRICE
IBRX$7.98COMPARE
COGT$34.93COMPARE
RCUS$29.86COMPARE
DNLI$22.53COMPARE
GPCR$46.95COMPARE
OCUL$10.63COMPARE
MESO$17.06COMPARE
AGIO$33.34COMPARE